Acquisition signal VitalFlo was acquired by Doktorconnect in May 2025, indicating strategic consolidation in proactive respiratory care. This suggests Doktorconnect may be expanding go-to-market capabilities, channel partnerships, or cross-sell opportunities with VitalFlo’s existing hospital and primary care customers.

Spirometry focus Core offering centers on fast, clinic and home-based spirometry with reimbursement potential. Leverage opportunities with hospitals and primary care networks seeking scalable lung health monitoring and efficient testing workflows that align with insurance codes.

Growth potential Revenue range indicates a small but growing ARR footprint. Target mid-market health systems and multi-site practices looking to standardize respiratory assessment and capture incremental reimbursement through remote monitoring and at-home testing.

Strategic partnerships History of partnerships with Vitalograph for remote devices and Ambee for environmental data signals openness to ecosystem collaborations. Identify opportunities with device manufacturers, AI-driven health analytics platforms, and environmental health partners.

Expansion-ready services Past launches of home-based virtual care and primary care acceleration point to a scalable care model. Propose bundled offerings combining in-clinic spirometry, at-home monitoring, and virtual care coordination to attract health systems pursuing value-based care and cost reduction.